Amy S Duffield

Assistant Professor

20032019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Amy S Duffield is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 9 Similar Profiles
Acute Myeloid Leukemia Medicine & Life Sciences
Protein-Tyrosine Kinases Medicine & Life Sciences
Leukemia Medicine & Life Sciences
Lymphoma Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Mutation Medicine & Life Sciences
Bone Marrow Medicine & Life Sciences
Biopsy Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2003 2019

Chronic Lymphocytic Leukemia Resulting in Hemorrhagic Brain Masses After Sepsis

Gusdon, A. M., Cho, S. M., Mayasi, Y., Malani, R., Puttgen, H. A., Duffield, A. S., Bolanos Meade, F. J. & Lim, M., Jan 1 2019, In : Neurohospitalist.

Research output: Contribution to journalArticle

B-Cell Chronic Lymphocytic Leukemia
Sepsis
Brain
Central Nervous System
Neurologic Examination

HTLV-1-associated adult T-cell leukemia/lymphoma with disseminated strongyloidiasis

Kwon, R. & Duffield, A. S., Jan 1 2019, In : Blood. 133, 24, 1 p.

Research output: Contribution to journalComment/debate

Open Access
Strongyloidiasis
Adult T Cell Leukemia Lymphoma
Human T-lymphotropic virus 1
T-cells

A multi-center phase i trial of ipilimumab in patients with myelodysplastic syndromes following hypomethylating agent failure

Zeidan, A. M., Knaus, H. A., Robinson, T., Towlerton, A. M. H., Warren, E. H., Zeidner, J. F., Blackford, A. L., Duffield, A. S., Rizzieri, D., Frattini, M. G., Levy, Y. M., Schroeder, M. A., Ferguson, A., Sheldon, K. E., Dezern, A., Gojo, I., Gore, S. D., Streicher, H., Luznik, L. & Smith, B. D., Aug 1 2018, In : Clinical Cancer Research. 24, 15, p. 3519-3527 9 p.

Research output: Contribution to journalArticle

Myelodysplastic Syndromes
ipilimumab
Inducible T-Cell Co-Stimulator Protein
Bone Marrow
T-Lymphocytes

Combination of ATO with FLT3 TKIs eliminates FLT3/ITD+ leukemia cells through reduced expression of FLT3

Nagai, K., Hou, L., Li, L., Nguyen, B., Seale, T., Shirley, C., Ma, H., Levis, M. J., Ghiaur, G., Duffield, A. S. & Small, D., Aug 31 2018, In : Oncotarget. 9, 68, p. 32885-32899 15 p.

Research output: Contribution to journalArticle

Protein-Tyrosine Kinases
Leukemia
Acute Myeloid Leukemia
Acute Promyelocytic Leukemia
Ubiquitination

Expanding the Spectrum of EBV-positive Marginal Zone Lymphomas: A Lesion Associated With Diverse Immunodeficiency Settings

Gong, S., Crane, G. M., McCall, C. M., Xiao, W., Ganapathi, K. A., Cuka, N., Davies-Hill, T., Xi, L., Raffeld, M., Pittaluga, S., Duffield, A. S. & Jaffe, E. S., Jun 27 2018, (Accepted/In press) In : American Journal of Surgical Pathology.

Research output: Contribution to journalArticle

Human Herpesvirus 4
Lymphoma
Lymphoproliferative Disorders
Immunosuppression
Immunoglobulin Genes